Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 2, 2007, Pages 133-137

  Hartmann, Dirk ^a   Eickhoff, Axel ^a   Damian, Ulrich ^a   Riemann, Juergen F ^a   Schilling, Dieter ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Esomeprazole; Gastric acidity; Helicobacter pylori; Intragastric pH; Pantoprazole

Indexed keywords

ESOMEPRAZOLE; PANTOPRAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG INDUCED HEADACHE; FEMALE; GASTRIC PH MONITORING; HELICOBACTER PYLORI; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH; UNSPECIFIED SIDE EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; BODY CONSTITUTION; CROSS-OVER STUDIES; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OMEPRAZOLE;

EID: 33846783065     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000252628.57925.32     Document Type: Article

References (11)

1. Wara P. Endoscopic prediction of major rebleeding: a prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology 1985; 88:1209-1214.
2. Green FW, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 1978; 74:38-43.
3. Cederberg C, Röhss K, Lundborg P, OIbe L. Effect of once daily intravenous and oral omeprazole on 24 h intragastric acidicity in healthy subjects. Scand J Gastroenterol 1993; 28:179-184.
4. Jansen JB, Lundborg P, Baak LC, Greve J, Ohman M, Stover C. Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmakokinetics in man. Gut 1988; 29:75-78.
5. Wilder-Smith CH, Rohss K, Bondarov P, Hallerback B, Svedberg LE, Ahlbom H. Esomeprazole 40mg iv provides faster and more effective intragastric acid control than pantoprazole 40mg iv: results of a randomized study. Aliment Pharmacol Ther 2004; 20:1099-1104.
6. Wilder-Smith C, Röhss K, Bondarov P, Lundin C, Nilsson-Pieschl C. Esomeprazole 40mg administrated intravenously (i.v.) as a 3 min injection or 30-min infusion provides the same effective acid control in healthy subjects. Gastroenterology 2003; 124 (Suppl 1):A-233.
7. Armstrong D, Bair D, James C, Tanser L, Escobedo S, Nevin K. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects. Aliment Pharmacol Ther 2003; 18:705-711.
8. Metz DC, Pratha V, Martin P, Paul J, Maton PN, Lew E, Pisegna JR. Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroesophageal reflux disease. Am J Gastroenterol 2000; 95:626-633.
9. Verdu EF, Armstrong D, Fraser R, Viani F, Idstrom JP, Cederberg C, Blum AL. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36:539-543.
10. Verdu EF, Armstrong D, Idstrom JP, Labenz J, Stolte M, Dorta G, et al. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut 1995; 37:743-748.
11. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343:310-316.